Log In
BCIQ
Print this Print this
 

PEX-168

  Manage Alerts
Collapse Summary General Information
Company Jiangsu Hansoh Pharmaceutical Co. Ltd.
Description 
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationDiabetes
Indication DetailsTreat Tyep II diabetes
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today